United HerlthのQ2収益はわずかに不足したが,収益は12.9%上昇し,2025年度の収益ガイドが上がった. UnitedHealth's Q2 earnings missed slightly, but revenue rose 12.9%, and it raised 2025 profit guidance.

ユナイテッド・ヘルス・グループは,第2四半期に1株当たり4.08ドル,予想をわずかに下回り,11162億ドルの収益を報告し,前年比12.9%の増加を示した. UnitedHealth Group reported second-quarter earnings of $4.08 per share, slightly below expectations, on $111.62 billion in revenue, a 12.9% year-over-year increase. 株式は344.15ドル,市場資本で3101.69億円で取引されているが,P/e比は141.1991と2.6%の配当収収額は2.6%である. The stock, trading at $344.15 with a market cap of $311.69 billion, has a P/E ratio of 14.91 and a 2.6% dividend yield. 複雑なアナリストの感情にかかわらず,同社は"モデレート・バイヤー"の評価率と平均価格の358.95ドルを掲げる. Despite mixed analyst sentiment, the company holds a "Moderate Buy" consensus rating and a $358.95 average price target. ユナイテッド・ヘルスでは2025年のEPSの予測を16.00ドルに上げ,アナリストはより高い収益を予測している. UnitedHealth raised its 2025 EPS guidance to $16.00, while analysts project higher earnings. 同社は4つのセグメント,UnitedHealthcare,Optum Health,Optum Insight,Optum Rxを通じて事業を展開し,米国全土で健康保険,医療サービス,データ分析,薬局サービスを提供している. The firm operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx, providing health benefits, care delivery, data analytics, and pharmacy services across the U.S. Institutional ownership remains high at 87.86%.